ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional Accepts healthy volunteers

Safety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Prior Pneumococcal Vaccination

ClinicalTrials.gov ID: NCT07425392

Public ClinicalTrials.gov record NCT07425392. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 1:24 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind, Active-Controlled Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 in Healthy Subjects 50 Years of Age and Older With Prior Pneumococcal Vaccination

Study identification

NCT ID
NCT07425392
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Vaxcyte, Inc.
Industry
Enrollment
752 participants

Conditions and interventions

Interventions

  • 31-valent pneumococcal conjugate vaccine Biological
  • PCV20 Biological

Biological

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 8, 2026
Primary completion
Feb 28, 2027
Completion
Feb 28, 2027
Last update posted
May 13, 2026

2026 – 2027

United States locations

U.S. sites
30
U.S. states
18
U.S. cities
30
Facility City State ZIP Site status
Chinle Center for Indigenous Health Chinle Arizona 86503
Avacare (CCT Research) Phoenix Arizona 85044
Whiteriver Center for Indigenous Health Whiteriver Arizona 85941
Chase Medical Research Waterbury Connecticut 06708
CenExel (RCA) Hollywood Florida 33024
Eximia (Health Awareness) Jupiter Florida 33458
Eximia (Health Awareness) Port Saint Lucie Florida 34952
Precision Clinical Research Sunrise Florida 33351
The Villages The Villages Florida 32162
DelRicht Clinical Research Stockbridge Georgia 30281
Velocity Clinical Valparaiso Valparaiso Indiana 46383
Johnson County Clin-Trials, LLC Lenexa Kansas 66219
DelRicht Clinical Research New Orleans Louisiana 70115
Velocity (Meridian Clinical Research) Rockville Maryland 20854
DM Clinical Research-Detroit Southfield Michigan 48076
AMR Kansas City Missouri 64114
DelRicht Research (Command Family Medicine) Springfield Missouri 65807
Quality Clinical Research Omaha Nebraska 68114
Center of American Indian Health Gallup New Mexico 87301
Shiprock Center for Indigenous Health Shiprock New Mexico 87420
Rochester Clinical Research, Inc. Rochester New York 14609
Headlands (Trial Management Associates) Wilmington North Carolina 28403
Tekton Research Edmond Oklahoma 73013
DelRicht Research Hendersonville Tennessee 37075
Tekton Research Austin Texas 78745
REX Clinical Trials Beaumont Texas 77701
Flourish Research San Antonio Texas 78229
DM Clinical Research Sugar Land Texas 77478
Alcanza (Charlottesville Medical Research) Charlottesville Virginia 22911
Health Research of Hampton Roads, Inc. Newport News Virginia 23606

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07425392, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 13, 2026 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07425392 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →